You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 14, April 8, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •JAMA Report Video
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Exercise
 •Cardiovascular System
 •Quality of Care
 •Patient Safety/ Medical Error
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

HF-ACTION Randomized Controlled Trial

Christopher M. O’Connor, MD; David J. Whellan, MD, MHS; Kerry L. Lee, PhD; Steven J. Keteyian, PhD; Lawton S. Cooper, MD, MPH; Stephen J. Ellis, PhD; Eric S. Leifer, PhD; William E. Kraus, MD; Dalane W. Kitzman, MD; James A. Blumenthal, PhD; David S. Rendall, PA-C; Nancy Houston Miller, RN, BSN; Jerome L. Fleg, MD; Kevin A. Schulman, MD; Robert S. McKelvie, MD, PhD; Faiez Zannad, MD, PhD; Ileana L. Piña, MD; for the HF-ACTION Investigators

JAMA. 2009;301(14):1439-1450.

Context  Guidelines recommend that exercise training be considered for medically stable outpatients with heart failure. Previous studies have not had adequate statistical power to measure the effects of exercise training on clinical outcomes.

Objective  To test the efficacy and safety of exercise training among patients with heart failure.

Design, Setting, and Patients  Multicenter, randomized controlled trial of 2331 medically stable outpatients with heart failure and reduced ejection fraction. Participants in Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) were randomized from April 2003 through February 2007 at 82 centers within the United States, Canada, and France; median follow-up was 30 months.

Interventions  Usual care plus aerobic exercise training, consisting of 36 supervised sessions followed by home-based training, or usual care alone.

Main Outcome Measures  Composite primary end point of all-cause mortality or hospitalization and prespecified secondary end points of all-cause mortality, cardiovascular mortality or cardiovascular hospitalization, and cardiovascular mortality or heart failure hospitalization.

Results  The median age was 59 years, 28% were women, and 37% had New York Heart Association class III or IV symptoms. Heart failure etiology was ischemic in 51%, and median left ventricular ejection fraction was 25%. Exercise adherence decreased from a median of 95 minutes per week during months 4 through 6 of follow-up to 74 minutes per week during months 10 through 12. A total of 759 patients (65%) in the exercise training group died or were hospitalized compared with 796 patients (68%) in the usual care group (hazard ratio [HR], 0.93 [95% confidence interval {CI}, 0.84-1.02]; P = .13). There were nonsignificant reductions in the exercise training group for mortality (189 patients [16%] in the exercise training group vs 198 patients [17%] in the usual care group; HR, 0.96 [95% CI, 0.79-1.17]; P = .70), cardiovascular mortality or cardiovascular hospitalization (632 [55%] in the exercise training group vs 677 [58%] in the usual care group; HR, 0.92 [95% CI, 0.83-1.03]; P = .14), and cardiovascular mortality or heart failure hospitalization (344 [30%] in the exercise training group vs 393 [34%] in the usual care group; HR, 0.87 [95% CI, 0.75-1.00]; P = .06). In prespecified supplementary analyses adjusting for highly prognostic baseline characteristics, the HRs were 0.89 (95% CI, 0.81-0.99; P = .03) for all-cause mortality or hospitalization, 0.91 (95% CI, 0.82-1.01; P = .09) for cardiovascular mortality or cardiovascular hospitalization, and 0.85 (95% CI, 0.74-0.99; P = .03) for cardiovascular mortality or heart failure hospitalization. Other adverse events were similar between the groups.

Conclusions  In the protocol-specified primary analysis, exercise training resulted in nonsignificant reductions in the primary end point of all-cause mortality or hospitalization and in key secondary clinical end points. After adjustment for highly prognostic predictors of the primary end point, exercise training was associated with modest significant reductions for both all-cause mortality or hospitalization and cardiovascular mortality or heart failure hospitalization.

Trial Registration  clinicaltrials.gov Identifier: NCT00047437


Author Affiliations: Duke Clinical Research Institute (Drs O’Connor, Whellan, Lee, Ellis, and Schulman and Mr Rendall) and Departments of Medicine (Drs O’Connor, Kraus, and Schulman), Biostatistics and Bioinformatics (Dr Lee), and Psychiatry and Behavioral Sciences (Dr Blumenthal), Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania (Dr Whellan); Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan (Dr Keteyian); Divisions of Prevention and Population Sciences (Drs Cooper and Leifer) and Cardiovascular Diseases (Dr Fleg), National Heart, Lung, and Blood Institute, Bethesda, Maryland; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Dr Kitzman); Department of Medicine, Stanford University, Stanford, California (Ms Houston Miller); Hamilton Health Sciences, Hamilton, Ontario, Canada (Dr McKelvie); Centre d’Investigation Clinique, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire, Université Henri Poincaré, Nancy, France (Dr Zannad); and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Piña).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure: HF-ACTION Randomized Controlled Trial
Kathryn E. Flynn, Ileana L. Piña, David J. Whellan, Li Lin, James A. Blumenthal, Stephen J. Ellis, Lawrence J. Fine, Jonathan G. Howlett, Steven J. Keteyian, Dalane W. Kitzman, William E. Kraus, Nancy Houston Miller, Kevin A. Schulman, John A. Spertus, Christopher M. O’Connor, and Kevin P. Weinfurt
JAMA. 2009;301(14):1451-1459.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis et al.
J Am Coll Cardiol 2009;54:1747-1762.
ABSTRACT | FULL TEXT  

Exercise training as a treatment for heart failure: potential mechanisms and clinical implications
Benito and Nattel
J. Physiol. 2009;587:5011-5013.
FULL TEXT  

Method for Establishing Authorship in a Multicenter Clinical Trial
Whellan et al.
ANN INTERN MED 2009;151:414-420.
ABSTRACT | FULL TEXT  

Remix: Exercise Training and Cardiac Resynchronization Therapy in Heart Failure
Rubin
J Am Coll Cardiol 2009;53:2340-2342.
FULL TEXT  

Exercise Training for Heart Failure Patients
JWatch General 2009;2009:5-5.
FULL TEXT  

All you need to read in the other general journals
BMJ 2009;338:b1526-b1526.
FULL TEXT  

Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure: HF-ACTION Randomized Controlled Trial
Flynn et al.
JAMA 2009;301:1451-1459.
ABSTRACT | FULL TEXT  

Exercise Training in Patients with LV Systolic Dysfunction
Journal Watch Cardiology 2009;2009:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.